Trial Profile
Phase III Clinical Study of Intravenous Administration of S-021812 in Pediatric Patients with Influenza Virus Infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Shionogi
- 27 May 2016 New trial record